Larimar Therapeutics Inc (NASDAQ:LRMR) price on Wednesday, April 30, rose 10.88% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.65.
A look at the stock’s price movement, the close in the last trading session was $2.39, moving within a range at $2.4 and $2.92. The beta value (5-Year monthly) was 0.906. Turning to its 52-week performance, $11.20 and $1.61 were the 52-week high and 52-week low respectively. Overall, LRMR moved 23.26% over the past month.
Larimar Therapeutics Inc’s market cap currently stands at around $169.68 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-23.
Turning to the stock’s technical picture we see that short term indicators suggest on average that LRMR is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend LRMR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
LRMR’s current price about 27.93% and 8.19% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 63.00, while 7-day volatility ratio is 9.81% and 10.65% in the 30-day chart. Further, Larimar Therapeutics Inc (LRMR) has a beta value of 0.95, and an average true range (ATR) of 0.22. Analysts have given the company’s stock an average 52-week price target of $15, forecast between a low of $15 and high of $15. Looking at the price targets, the low is -466.04% off current price level while to achieve the yearly target high, price needs to move -466.04%. Nonetheless, investors will most likely welcome a -466.04% jump to $15 which is the analysts’ median price.
If we refocus on Larimar Therapeutics Inc (NASDAQ:LRMR), historical trading data shows that trading volumes averaged 1.28 over the past 10 days and 815.69K over the past 3 months. The company’s latest data on shares outstanding shows there are 63.82 million shares.
The 42.71% of Larimar Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 65.16% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 5.63 million on 2025-04-15, giving us a short ratio of 5.41. The data shows that as of 2025-04-15 short interest in Larimar Therapeutics Inc (LRMR) stood at 1592.0000000000002 of shares outstanding, with shares short rising to 5.08 million registered in 2025-03-14. Current price change has pushed the stock -31.52% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the LRMR stock continues to rise going into the next quarter.
